Imunon, Inc.: 10-Q filed 2017-11-14

Name: Imunon, Inc.: 10-Q filed 2017-11-14
Creator: Imunon, Inc.

What Imunon, Inc. reported in its quarterly report filed 2017-11-14 (fiscal Q3 2017): 31 published measures, 84 facts as tagged in accession 0001437749-17-019215.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-11-14
Fiscal period: fiscal Q3 2017
Accession: 0001437749-17-019215 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Imunon, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2017-09-30	26,000,964	USD
At 2016-12-31	30,849,691	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2017-09-30	20,713,908	USD
At 2016-12-31	24,123,865	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2017-09-30	5,287,056	USD
At 2016-12-31	6,725,826	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2017-09-30	2,685,010	USD
At 2016-12-31	2,624,162	USD
At 2016-09-30	4,184,222	USD
At 2015-12-31	9,265,144	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-5,671,329	USD	92
2017-01-01 to 2017-09-30	-15,721,334	USD	273
2016-07-01 to 2016-09-30	-6,409,687	USD	92
2016-01-01 to 2016-09-30	-16,657,137	USD	274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	-12,433,179	USD	273
2016-01-01 to 2016-09-30	-13,716,405	USD	274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	21,126	USD	273
2016-01-01 to 2016-09-30	48,928	USD	274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	10,735,153	USD	273
2016-01-01 to 2016-09-30	2,399,536	USD	274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	1,758,874	USD	273
2016-01-01 to 2016-09-30	6,235,947	USD	274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-09-30	-257,101,046	USD
At 2016-12-31	-241,379,712	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2017-09-30	142,862	USD
At 2016-12-31	462,836	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	951,488	USD	273
2016-01-01 to 2016-09-30	1,331,094	USD	274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-4,398,097	USD	92
2017-01-01 to 2017-09-30	-13,787,236	USD	273
2016-07-01 to 2016-09-30	-5,596,603	USD	92
2016-01-01 to 2016-09-30	-15,515,976	USD	274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2017-09-30	2,774,312	USD
At 2016-12-31	4,512,578	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2017-09-30	5,997,174	USD
At 2016-12-31	8,423,287	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2017-09-30	2,806,201	USD
At 2016-12-31	2,878,978	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2017-09-30	1,976,101	USD
At 2016-12-31	1,976,101	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2017-09-30	852,437	USD
At 2016-12-31	1,022,924	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	4,523,097	USD	92
2017-01-01 to 2017-09-30	14,162,236	USD	273
2016-07-01 to 2016-09-30	5,721,603	USD	92
2016-01-01 to 2016-09-30	15,890,976	USD	274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	3,348,847	USD	92
2017-01-01 to 2017-09-30	9,870,754	USD	273
2016-07-01 to 2016-09-30	4,225,132	USD	92
2016-01-01 to 2016-09-30	11,002,675	USD	274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit
At 2017-09-30	8,354,679	shares
At 2017-05-16	4,070,172	shares
At 2017-05-15	56,982,418	shares
At 2016-12-31	2,230,118	shares

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2017-09-30	2,854,122	USD
At 2016-12-31	2,513,022	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2017-09-30	73,680	USD
At 2016-12-31	12,352	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2017-09-30	2,690,973	USD
At 2016-12-31	2,483,756	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-5,671,329	USD	92
2017-01-01 to 2017-09-30	-15,721,334	USD	273
2016-07-01 to 2016-09-30	-6,409,223	USD	92
2016-01-01 to 2016-09-30	-16,652,815	USD	274

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-5,671,329	USD	92
2017-01-01 to 2017-09-30	-16,067,019	USD	273
2016-07-01 to 2016-09-30	-6,409,687	USD	92
2016-01-01 to 2016-09-30	-16,657,137	USD	274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	1,174,250	USD	92
2017-01-01 to 2017-09-30	4,291,482	USD	273
2016-07-01 to 2016-09-30	1,496,471	USD	92
2016-01-01 to 2016-09-30	4,888,301	USD	274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	511,587	USD	273
2016-01-01 to 2016-09-30	365,625	USD	274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	93	USD	92
2017-01-01 to 2017-09-30	3,545	USD	273
2016-07-01 to 2016-09-30	2,218	USD	92
2016-01-01 to 2016-09-30	1,965	USD	274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-1,273,232	USD	92
2017-01-01 to 2017-09-30	-1,934,098	USD	273
2016-07-01 to 2016-09-30	-813,084	USD	92
2016-01-01 to 2016-09-30	-1,141,161	USD	274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	-72,777	USD	273
2016-01-01 to 2016-09-30	195,716	USD	274

Inspect the source

Entity: Imunon, Inc. / CIK 0000749647
Captured: 2026-09-19T15:01:50.763Z
SEC response SHA-256: cf2e46071525a607b4d539753f5129368297f1e667d6fa4f8829e76132e7a85a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000749647.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))